Addiction and smoking dependency involve complex physiological and psychological reliance on substances like nicotine, alcohol, or opioids. Medications in this category work by modulating neurotransmitters or blocking receptors to reduce cravings and withdrawal symptoms. Some treatments provide deterrent effects or stabilise brain chemistry to support long-term recovery goals. These regulated treatments are available through our licensed pharmacy to support patients in managing various chemical dependencies.
Addiction & Quit Smoking is a therapeutic area that focuses on helping people reduce or stop the use of nicotine, alcohol and opioids. It addresses the physical and psychological aspects of dependence, acknowledging that quitting can be a gradual process that involves changes in brain chemistry as well as daily habits. The aim of treatment in this field is to give individuals the support they need to manage cravings, cope with withdrawal and rebuild a healthier routine.
Medications that belong to the Addiction & Quit Smoking group include Bupropion, Varenicline and Naltrexone, among others. These medicines work in different ways, such as reducing the pleasure derived from the substance or easing withdrawal sensations. They are typically part of a broader plan that may also involve counselling, support groups and lifestyle adjustments.
People turn to these options when they want a structured approach to quitting smoking, cutting down alcohol intake or supporting recovery from opioid dependence. Understanding the range of available treatments helps patients choose a path that matches their personal circumstances and goals.
Secondary conditions that frequently accompany these primary dependencies include anxiety, depression and sleep disturbances. Common symptoms range from intense urges to use the substance, irritability, mood swings, and physical sensations such as tremors or nausea during withdrawal periods. These effects can impact work performance, relationships and overall quality of life, making it harder to maintain abstinence without support.
These categories intersect with Addiction & Quit Smoking by addressing overlapping aspects of dependence, but each concentrates on a specific therapeutic angle.
These medicines can help lessen cravings and improve mood stability. Bupropion is a widely used option that works on neurotransmitters linked to motivation and pleasure.
Designed to reduce the rewarding effects of nicotine while easing withdrawal. Varenicline and its tartrate formulation belong to this class, providing a smoother transition away from smoking.
Target the brain’s response to opioid substances. Naltrexone is employed to block the pleasurable sensations associated with opioid and alcohol use, supporting individuals who wish to stay abstinent.
These compounds produce unpleasant reactions when alcohol is consumed, discouraging further drinking. Disulfiram operates in this way, creating a physical reminder to avoid alcohol.
Aid in stabilising brain chemistry after alcohol cessation. Acamprosate and its calcium formulation help reduce cravings by influencing glutamate activity.
Each group serves a distinct purpose within the broader goal of reducing dependence, and the choice of medication depends on the specific substance being addressed and the individual’s health profile.
Addiction & Quit Smoking treatments are built on the principle that dependence is both a neurochemical and behavioural challenge. Medications act mainly on brain receptors to lessen the urge to use, while behavioural changes reinforce new, healthier habits. In many cases, treatment may be short-term, aimed at guiding the person through the most intense withdrawal phase, after which the medication is tapered off. For chronic users, a longer course may be considered to maintain stability and prevent relapse.
The therapeutic approach generally follows three steps: assessment of dependence severity, selection of an appropriate medication or combination, and integration with psychosocial support. Although each medication has its own mechanism, they share the common goal of making the quitting process more manageable and less distressing.
These scenarios illustrate the range of people who might consider Addiction & Quit Smoking medications as part of a comprehensive plan to regain control over substance use.
Nicotine dependence: A physiological and psychological reliance on nicotine that creates strong cravings and withdrawal symptoms when use stops.
Withdrawal syndrome: A set of physical and mental symptoms that appear when a person reduces or stops using an addictive substance.
Craving: An intense desire or urge to consume a specific substance, often triggered by environmental cues or stress.
Relapse: The return to substance use after a period of abstinence, commonly occurring when coping strategies are insufficient.
Opioid antagonist: A medication that blocks the effects of opioids at brain receptors, reducing the pleasure derived from opioid use.
Addiction & Quit Smoking refers to a group of medicines that help people manage cravings and withdrawal when they stop using nicotine, alcohol or opioids.
They act on brain pathways that control pleasure and reward, making the urge to use the substance less intense and easing the discomfort of withdrawal.
No, the category also includes treatments that support people with alcohol or opioid dependence, not just nicotine addiction.
Some drugs, such as Naltrexone, are effective for both alcohol and opioid dependence because they block the rewarding effects of both substances.
Options include tablets, extended-release tablets and, for certain agents, oral solutions. The form is chosen based on how the medicine is best absorbed and tolerated.
Treatment length varies; many people use the medication for several weeks to months to get through the most difficult withdrawal phase, after which it may be tapered.
Adopting healthier routines-such as regular exercise, balanced diet and avoiding triggers-can improve the chances of staying abstinent while using the medication.
The medicines in this category are not considered addictive in the same way as nicotine, alcohol or opioids, and they are designed to be used for a limited period.
Prescription medicines often target brain receptors directly, whereas nicotine patches provide a low, steady dose of nicotine to reduce withdrawal gradually.
Most users notice a reduction in cravings and a gradual easing of withdrawal symptoms, though the experience can differ depending on the specific medication and the substance being addressed.
